In vitro diagnostic (IVD) Procedure Volumes 2020-2025 Report Gives Insight into Test Procedure Volumes and Pricing - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "IVD Procedure Volumes 2020-2025" report has been added to ResearchAndMarkets.com's offering.

In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in the IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner.

IVD Test Procedure Volumes estimates IVD test procedure volume and IVD pricing for the following segments:

• Worldwide IVD Market and Test Volume
• Point-of-Care Market and Test Volume
• Clinical Chemistry Market and Test Volume
• Molecular Market and Test Volume
• Hematology Market and Test Volume
• Coagulation Market and Test Volume
• Microbiology Market and Test Volume
• Blood Screening Market and Test Volume
• Histology/Cytology Market and Test Volume
• Immunoassay Market and Test Volume
• IVD Testing Segments and Global IVD Markets

The report includes estimates of average fees paid to clinical laboratories and medical establishments for specific groups of IVD procedures. In addition, list prices published by producers are provided for selected IVD tests, reagents, and instruments. A table that measures the total amount of IVD product sales against the total volume of IVD procedures is presented for each major testing category. The IVD market, defined in procedure volume and pricing tables, makes up the market data in this report. Procedure volume estimates are provided for various categories, and average selling price (ASP) for tests are calculated.

The report provides the following molecular assay data points:

• Molecular Assay Procedural Volume by Type (millions), 2020-2025 (Infectious Diseases, Blood Screening, Cancer Testing, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
• Molecular Assay Infectious Disease Procedural Volume by Type (millions), 2020-2025 (HAIs, Hepatitis, HIV, HPV, GC/Chlamydia, Respiratory, Mycobacteria/TB, Organism ID, Other)
• Molecular Assay Product Sales by Type ($ millions), 2020-2025 (Infectious Diseases, Blood Screening, Cancer Testing, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
• Molecular Assay Infectious Disease Product Sales by Type ($ millions), 2020-2025 (HAIs, Hepatitis, HIV, HPV, GC/Chlamydia, Respiratory, Mycobacteria/TB, Organism ID, Other)
• Molecular Assays $ Products per Procedure by Type, 2020-2025 (Infectious Diseases, Blood Screening, Cancer Testing, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
• Hematology Procedures

The report provides the following data points with respect to hematology procedures:

• Hematology Procedural Volume by Type (millions), 2020-2025 (Complete Blood Count, Other Hematology Tests)
• Hematology Product Sales by Type ($ millions), 2020-2025 (Complete Blood Count, Other Hematology Tests)
• Hematology $ Product Sales Per Procedure by Type, 2020-2025 (Complete Blood Count, Other Hematology Tests)
• Coagulation Testing Procedures

The report provides the following coagulation testing data points:

• Coagulation Procedural Volume (millions), 2020-2025
• Coagulation Product Sales ($ millions), 2020-2025
• Coagulation $ Products per Procedure, 2020-2025
• Microbiology Procedures

IVD Test Procedure Volumes provides the following data points with respect to microbiology procedures:

• Conventional Microbiology Procedural Volume by Type (millions), 2020-2025 (Chromogenic Media, ID/AST Automated Panels/Reagents, ID/AST Manual Panels/Reagents, Blood Culture, Rapid Microbiological Tests)
• Conventional Microbiology Product Sales by Type ($ millions), 2020-2025 (Chromogenic Media, ID/AST Automated Panels/Reagents, ID/AST Manual Panels/Reagents, Blood Culture, Rapid Microbiological Tests)
• Conventional Microbiology $ Product Sales Per Procedures by Type, 2020-2025 (Chromogenic Media, ID/AST Automated Panels/Reagents, ID/AST Manual Panels/Reagents, Blood Culture, Rapid Microbiological Tests)
• Blood Grouping/Typing Procedures

The blood banking segment applies IVD products to three major applications: the screening of donated blood for viral antigens, the matching of blood types between organ donors and recipients, and the identification of blood grouping and platelet antibodies. The report provides estimates of procedures, product sales, and prices appearing applying to blood grouping and typing functions only:

• Blood Grouping/Matching Procedural Volume (millions), 2020-2025
• Blood Grouping/Matching Product Sales ($ millions), 2020-2025
• Blood Grouping/Matching $ Product Sales/Procedure, 2020-2025
• Histology/Cytology Procedures

The report provides the following histology/cytology data points:

• Histology/Cytology Procedural Volume by Type (millions), 2020-2025 (In Situ Hybridization, Immunohistochemistry, Pap Tests, Traditional Non-Pap Stains, Circulating Tumor Cells)
• Histology/Cytology Product Sales by Type ($ millions), 2020-2025 (In Situ Hybridization, Immunohistochemistry, Pap Tests, Traditional Non-Pap Stains, Circulating Tumor Cells)
• Histology/Cytology $ Product Sales Per Procedure by Type, 2020-2025 (In Situ Hybridization, Immunohistochemistry, Pap Tests, Traditional Non-Pap Stains, Circulating Tumor Cells)
• Immunoassay Procedures

IVD Test Procedure Volumes, 2020-2025 includes profiles of the top twelve IVD market competitors, looking in detail where possible at procedural volume by type.

The companies covered are the following:

• Abbott Laboratories
• Becton, Dickinson and Company (BD)
• bioMerieux Inc.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Hologic, Inc.
• Ortho Clinical Diagnostics (Ortho)
• QIAGEN N.V.
• Roche
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/tpxs7u